VBI Vaccines Inc/BC
VBIVDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000764195
VBI Vaccines Inc/BC was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jul 31, 2023; 41 institutions reported holding it in 13F filings for Q2 2024, worth $1.79M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 41
- Q2 2024, +5 vs. previous quarter
- 13F value
- $1.79M
- Reported value at the end of Q2 2024
- Superinvestors holding
- 0
- At the end of Q2 2024
Superinvestors holding VBIV, Q2 2024
No superinvestor reported holding VBIV at the end of Q2 2024.
Latest insider trades
Open-market purchases and sales by VBI Vaccines Inc/BC insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2023 (view filing) | Jul 10 | 8 daysLate | Gillis StevenDirector | PPurchaseCommon Shares, no par value per share | +609.1K | $1.65 | +$1.00M | +140.3%1.04M after | |
| Jul 18, 2023 (view filing) | Jul 10 | 8 daysLate | Gillis StevenDirector | PPurchase | −609.1K | – | – | –609.1K after | Derivative |
| Apr 6, 2023 (view filing)5:51 PM ET | Apr 4-6 | 2 days | Edelman Joseph and 2 others10% Owner | SSale | −10.9M | $0.1354 | −$1.48M | −20.8%41.4M after | 3 lots |
| Dec 6, 2021 (view filing) | Dec 3 | 3 days | Beattie NellChief Business Officer | PPurchaseCommon Shares, no par value per share | +8.20K | $2.45 | +$20.1K | +13.7%68.2K after | |
| Dec 3, 2021 (view filing)6:22 PM ET | Dec 1 | 2 days | Edelman Joseph and 2 others10% Owner | SSale | −2.71M | $3.31 | −$8.96M | −4.9%52.3M after |
Top 10 13F holders, Q2 2024
The largest institutional positions in VBI Vaccines Inc/BC at the end of Q2 2024; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 1,261,710 | $832.7K | 0.02% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 608,604 | $401.7K | 0.00% | −17,832−2.8% | Reduced |
| Vanguard Group Inc | 184,436 | $121.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 178,822 | $118.0K | 0.00% | +35,201+24.5% | Added |
| BlackRock Inc. | 108,591 | $71.7K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 67,113 | $44.0K | 0.00% | −16,969−20.2% | Reduced |
| State Street Corp | 43,894 | $29.0K | 0.00% | +13,844+46.1% | Added |
| Northern Trust Corp | 32,916 | $21.7K | 0.00% | −76−0.2% | Reduced |
| Morgan Stanley | 32,126 | $21.2K | 0.00% | −22−0.1% | Reduced |
| Renaissance Technologies LLC | 28,742 | $19.0K | 0.00% | −28,599−49.9% | Reduced |